Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.200
+0.020 (1.69%)
Sep 11, 2026, 3:59 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.44 billion as of September 11, 2026. Its market cap has decreased by -16.41% in one year.
Market Cap
2.44B
Enterprise Value
3.27B
Revenue
2.18B
Ranking
n/a
PE Ratio
29.42
Stock Price
1.20
ChartMarket Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.44B, a decrease of -63.71%. That is a compound annual growth rate of -12.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.44B | 20.38% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Recbio Technology | 3.08B |
| BioDlink International Company | 2.91B |
| Laekna | 2.87B |
| Medtide | 2.84B |
| Viva Biotech Holdings | 2.79B |
| Clover Biopharmaceuticals | 2.73B |
| Beijing Luzhu Biotechnology | 2.69B |
| Antengene Corporation | 2.38B |